Oligonucleotide microarray identifies genes differentially expressed during tumorigenesis of DMBA-induced pancreatic cancer in rats

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Guo, Jun Chao ^a   Li, Jian ^a   Yang, Ying Chi ^a   Zhou, Li ^a   Zhang, Tai Ping ^a   Zhao, Yu Pei ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; CHEMOKINE RECEPTOR CXCR7;

ACUTE PANCREATITIS; ADULT; ADVANCED CANCER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER STAGING; CARCINOGENESIS; CHRONIC PANCREATITIS; CONTROLLED STUDY; CXCR7 GENE; DOWN REGULATION; EARLY CANCER; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MICROARRAY ANALYSIS; NONHUMAN; OLIGONUCLEOTIDE MICROARRAY; PANCREAS ADENOMA; PANCREAS CANCER; RAT; REAL TIME POLYMERASE CHAIN REACTION; UBE2C GENE; UPREGULATION;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CARCINOGENESIS; CELL LINE, TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MOLECULAR SEQUENCE ANNOTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PANCREAS; PANCREATIC NEOPLASMS; PANCREATITIS, ACUTE NECROTIZING; PANCREATITIS, CHRONIC; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CXCR; TUMOR MARKERS, BIOLOGICAL; UBIQUITIN-CONJUGATING ENZYMES;

EID: 84893518892     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082910     Document Type: Article

References (37)

1. Hidalgo M (2010) Pancreatic cancer. N Engl J Med 362: 1605-1617.
2. Weber A, Kehl V, Mittermeyer T, Herberich E, Rothling N, et al. (2010) Prognostic factors for survival in patients with unresectable pancreatic cancer. Pancreas 39: 1247-1253.
3. Hallemeier CL, Botros M, Corsini MM, Haddock MG, Gunderson LL, et al. (2011) Preoperative CA 19-9 level is an important prognostic factor in patients with pancreatic adenocarcinoma treated with surgical resection and adjuvant concurrent chemoradiotherapy. Am J Clin Oncol 34: 567-572.
4. Robinson SM, Rahman A, Haugk B, French JJ, Manas DM, et al. (2012) Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma. Eur J Surg Oncol 38: 333-339.
5. Chatterjee D, Katz MH, Rashid A, Wang H, Iuga AC, et al. (2012) Perineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinoma. Am J Surg Pathol 36: 409-417.
6. Gingell R, Wallcave L, Nagel D, Kupper R, Pour P (1976) Metabolism of the pancreatic carcinogens N-nitroso-bis(2-oxopropyl)amine and N-nitroso-bis(2- hydroxypropyl)amine in the Syrian hamster. J Natl Cancer Inst 57: 1175-1178.
7. Pour P, Mohr U, Cardesa A, Althoff J, Kruger FW (1975) Pancreatic neoplasms in an animal model: morphological, biological, and comparative studies. Cancer 36: 379-389.
8. Longnecker DS, Curphey TJ (1975) Adenocarcinoma of the pancreas in azaserine-treated rats. Cancer Res 35: 2249-2258.
9. Roebuck BD, Baumgartner KJ, Thron CD (1984) Characterization of two populations of pancreatic atypical acinar cell foci induced by azaserine in the rat. Lab Invest 50: 141-146. (Pubitemid 14199075)
10. Osvaldt AB, Wendt LR, Bersch VP, Backes AN, de Cassia A, et al. (2006) Pancreatic intraepithelial neoplasia and ductal adenocarcinoma induced by DMBA in mice. Surgery 140: 803-809. (Pubitemid 44754985)
11. Rivera JA, Graeme-Cook F, Werner J, Z'graggen K, Rustgi AK, et al. (1997) A rat model of pancreatic ductal adenocarcinoma: targeting chemical carcinogens. Surgery 122: 82-90. (Pubitemid 27295171)
12. Jimenez RE, Z'graggen K, Hartwig W, Graeme-Cook F, Warshaw AL, et al (1999) Immunohistochemical characterization of pancreatic tumors induced by dimethylbenzanthracene in rats. Am J Pathol 154: 1223-1229.
13. Z'graggen K, Warshaw AL, Werner J, Graeme-Cook F, Jimenez RE, et al. (2001) Promoting effect of a high-fat/high-protein diet in DMBA-induced ductal pancreatic cancer in rats. Ann Surg 233: 688-695.
14. Bockman DE, Guo J, Buchler P, Muller MW, Bergmann F, et al. (2003) Origin and development of the precursor lesions in experimental pancreatic cancer in rats. Lab Invest 83: 853-859. (Pubitemid 36723694)
15. Boros LG, Lerner MR, Morgan DL, Taylor SL, Smith BJ, et al. (2005) [1,2-13C2]-D-glucose profiles of the serum, liver, pancreas, and DMBA-induced pancreatic tumors of rats. Pancreas 31: 337-343. (Pubitemid 41566882)
16. Tan XG, Yang ZL (2010) Expression of Ezrin, HGF, C-met in pancreatic cancer and non-cancerous pancreatic tissues of rats. Hepatobiliary Pancreat Dis Int 9: 639-644.
17. Wang L, Liu HL, Li Y, Yuan P (2011) Proteomic analysis of pancreatic intraepithelial neoplasia and pancreatic carcinoma in rat models. World J Gastroenterol 17: 1434-1441.
18. Bockman DE, Guo J, Buchler P, Muller MW, Bergmann F, et al. (2003) Origin and development of the precursor lesions in experimental pancreatic cancer in rats. Lab Invest 83: 853-859. (Pubitemid 36723694)
19. Eser S, Reiff N, Messer M, Seidler B, Gottschalk K, et al. (2013) Selective requirement of PI3K/PDK1 signaling for Kras oncogene-driven pancreatic cell plasticity and cancer. Cancer Cell 23: 406-420.
20. Lieber M, Mazzetta J, Nelson-Rees W, Kaplan M, Todaro G (1975) Establishment of a continuous tumor-cell line (panc-1) from a human carcinoma of the exocrine pancreas. Int J Cancer 15: 741-747.
21. Drucker BJ, Marincola FM, Siao DY, Donlon TA, Bangs CD, et al. (1988) A new human pancreatic carcinoma cell line developed for adoptive immunotherapy studies with lymphokine-activated killer cells in nude mice. In Vitro Cell Dev Biol 24: 1179-1187. (Pubitemid 19045970)
22. Herreros-Villanueva M, Hijona E, Cosme A, Bujanda L (2012) Mouse models of pancreatic cancer. World J Gastroenterol 18: 1286-1294.
23. Zhao YP, Chen G, Feng B, Zhang TP, Ma EL, et al. (2007) Microarray analysis of gene expression profile of multidrug resistance in pancreatic cancer. Chin Med J (Engl) 120: 1743-1752. (Pubitemid 350111076)
24. Kalinina T, Gungor C, Thieltges S, Moller-Krull M, Penas EM, et al. (2010) Establishment and characterization of a new human pancreatic adenocarcinoma cell line with high metastatic potential to the lung. BMC Cancer 10: 295.
25. Rogers A, Smith MJ, Doolan P, Clarke C, Clynes M, et al. (2012) Invasive markers identified by gene expression profiling in pancreatic cancer. Pancreatology 12: 130-140.
26. Zhang L, Farrell JJ, Zhou H, Elashoff D, Akin D, et al. (2010) Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer. Gastroenterology 138: 949-957. e1-7.
27. Biankin AV, Waddell N, Kassahn KS, Gingras MC, Muthuswamy LB, et al. (2012) Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature 491: 399-405.
28. Yasuda D, Iguchi H, Ikeda Y, Nishimura S, Steeg P, et al. (1993) Possible association of nm23 gene-expression and ki-ras point mutations with metastatic potential in human pancreatic cancer-derived cell-lines. Int J Oncol 3: 641-644. (Pubitemid 23296374)
29. Ito Y, Takeda T, Wakasa K, Tsujimoto M, Okada M, et al. (2002) Expression of the G2-M modulators in pancreatic adenocarcinoma. Pancreatology 2: 138-145. (Pubitemid 34639089)
30. Hattermann K, Held-Feindt J, Lucius R, Muerkoster SS, Penfold ME, et al. (2010) The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects. Cancer Res 70: 3299-3308.
31. Monnier J, Boissan M, L'Helgoualc'h A, Lacombe ML, Turlin B, et al. (2012) CXCR7 is up-regulated in human and murine hepatocellular carcinoma and is specifically expressed by endothelial cells. Eur J Cancer 48: 138-148.
32. Hao M, Zheng J, Hou K, Wang J, Chen X, et al. (2012) Role of chemokine receptor CXCR7 in bladder cancer progression. Biochem Pharmacol 84: 204-214.
33. Schrevel M, Karim R, ter HNT, van der Burg SH, Trimbos JB, et al. (2012) CXCR7 expression is associated with disease-free and disease-specific survival in cervical cancer patients. Br J Cancer 106: 1520-1525.
34. Heinrich EL, Lee W, Lu J, Lowy AM, Kim J (2012) Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells. J Transl Med 10: 68.
35. Marechal R, Demetter P, Nagy N, Berton A, Decaestecker C, et al. (2009) High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma. Br J Cancer 100: 1444-1451.
36. Gebauer F, Tachezy M, Effenberger K, von LK, Zander H, et al. (2011) Prognostic impact of CXCR4 and CXCR7 expression in pancreatic adenocarcinoma. J Surg Oncol 104: 140-145.
37. Hao Z, Zhang H, Cowell J (2012) Ubiquitin-conjugating enzyme UBE2C: molecular biology, role in tumorigenesis, and potential as a biomarker. Tumour Biol 33: 723-730.